In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Tenaya Therapeutics Inc (NASDAQ: TNYA) closed at $0.68 in the last session, down -6.45% from day before closing price of $0.73. In other words, the price has decreased by -$6.45 from its previous closing price. On the day, 2.48 million shares were traded. TNYA stock price reached its highest trading level at $0.7297 during the session, while it also had its lowest trading level at $0.66.
Ratios:
We take a closer look at TNYA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.22 and its Current Ratio is at 4.22. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.12.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 10 ’25 when Higa Tomohiro sold 2,482 shares for $0.54 per share. The transaction valued at 1,336 led to the insider holds 99,690 shares of the business.
Tingley Whittemore sold 7,398 shares of TNYA for $3,983 on Mar 10 ’25. The Chief Medical Officer now owns 174,793 shares after completing the transaction at $0.54 per share. On Mar 10 ’25, another insider, Ali Faraz, who serves as the Chief Executive Officer of the company, sold 9,741 shares for $0.54 each. As a result, the insider received 5,245 and left with 320,514 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 118685288 and an Enterprise Value of 11972189.
Stock Price History:
The Beta on a monthly basis for TNYA is 2.90, which has changed by -0.8606123 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, TNYA has reached a high of $5.39, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -34.19%, while the 200-Day Moving Average is calculated to be -69.67%.
Shares Statistics:
According to the various share statistics, TNYA traded on average about 3.84M shares per day over the past 3-months and 7762470 shares per day over the past 10 days. A total of 162.58M shares are outstanding, with a floating share count of 134.09M. Insiders hold about 17.52% of the company’s shares, while institutions hold 20.24% stake in the company. Shares short for TNYA as of 1740700800 were 14396125 with a Short Ratio of 3.75, compared to 1738281600 on 12242090. Therefore, it implies a Short% of Shares Outstanding of 14396125 and a Short% of Float of 26.02.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of Tenaya Therapeutics Inc (TNYA) is currently drawing attention from 6.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.14 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.59 and -$1.26 for the fiscal current year, implying an average EPS of -$0.78. EPS for the following year is -$0.81, with 5.0 analysts recommending between -$0.56 and -$1.24.
